Qihuang Needle Therapy for Parkinson's Disease: A Randomized Controlled Trial Protocol

Wanqing Peng's protocol document outlines a triple-arm randomized controlled trial investigating Qihuang needle therapy for Parkinson's disease. The trial, registered as ITMCTR2025000402, will enroll 69 patients to assess clinical efficacy and neuroplasticity via multimodal MRI. The document was last updated on 2026-04-13.

Use Cases

• Analyze clinical trial design and methodology for acupuncture studies based on the described triple-arm RCT protocol.
• Study neuroplasticity mechanisms in Parkinson's disease based on multimodal MRI markers described, including gray matter volume and functional connectivity.
• Investigate the integration of traditional Chinese medicine and Western medicine based on the protocol's stated aim to optimize integrative treatment strategies.

Strengths

• The protocol is a registered clinical trial (ITMCTR2025000402), providing a structured research framework.
• Describes a multimodal MRI approach to assess multiple neuroplasticity markers, including gray matter volume and nigral iron deposition.
• Includes a wait-list control group alongside verum and sham acupuncture arms for robust comparison.

Limitations

• The dataset is a 17.1 KB DOCX protocol document, not the actual clinical or imaging data.
• Column-level documentation for any potential data is absent; field semantics must be inferred after download.
• Row count for any associated data is unknown, which may limit suitability assessment.

Provenance

Source

Wanqing Peng via figshare.

Collection Method

Protocol document for a planned clinical trial.

Time Range

Protocol published in 2026; trial timeframe not specified.

Freshness

Last updated 2026-04-13 13:15:22; freshness should be verified.

Geography

Geography of the trial is not specified.